A phase 3b/4 safety trial of nivolumab in patients with advanced or metastatic NSCLC who have progressed druing or after receiving at least one prior systemic regimen by Lei Chen-Video Presentation-CSCO

OverSeas Account Chinese

Home
About CSCO
Meetings
Resource
Contact Us

A phase 3b/4 safety trial of nivolumab in patients with advanced or metastatic NSCLC who have progressed druing or after receiving at least one prior systemic regimen by Lei Chen

PUBLISHED: 2016-01-14 2123 total views, 2 today

News

2024 ESMO ASIA,Dec.6-8, Singapore
The memo inHaematology SPECIAL ISSUE...
memo inOncology SPECIAL ISSUE congres...
申请ASCO Conquer Cancer基金
ESMO ASIA Congress from 1 to 3 Decemb...

京公网安备 11010502031031号

EMAIL：office@csco.org.cn

international@csco.org.cn

Phone：86(10)67726451 (Beijing)

86(25)84547290 (Nanjing）